{"id":913861,"date":"2025-11-25T17:12:20","date_gmt":"2025-11-25T22:12:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/"},"modified":"2025-11-25T17:12:20","modified_gmt":"2025-11-25T22:12:20","slug":"tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","title":{"rendered":"TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Nov.  25, 2025  (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in\u00a0<strong>Telix Pharmaceuticals Ltd.<\/strong> (&#8220;Telix Pharmaceuticals Ltd.&#8221; or the &#8220;Company&#8221;) (NASDAQ: TLX) of a class action securities lawsuit.<\/p>\n<p>\n        <strong>CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of Telix Pharmaceuticals Ltd. investors who were adversely affected by alleged securities fraud between February 21, 2025 and August 28, 2025. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g8xrVeyUqa1-gZLH5fZRWHhvU7uB4IxYtcb7UVJCFb8MoJHAY674N7BRGLWB6AghL04wPg94EFnVCK2ypFdoW0-ebaZY7sH93E5MJqsqyHPBBSMvvCJYVewAiu3ePo9Gkpb2yiXzWlbEnkF1Uy_Buh4dkBJ3COjnp7YLUDA1rCkN7Bz_xTpZFHWprqF7_KdEUC28EEQAZo7UocsDg7_oipKHSO2oI6kaVKoWRkjWydhlfGIbCwbwcsS8czR5is8DxZoYevy3Mx-KhBA6nDIxLmL7-_XaODzxIT2FJ_OTubA=\" rel=\"nofollow\" target=\"_blank\">https:\/\/zlk.com\/pslra-1\/telix-pharmaceuticals-ltd-lawsuit-submission-form?prid=178928&amp;wire=3<\/a>\n      <\/p>\n<p>\n        <strong>TLX<\/strong> investors may also contact Joseph E. Levi, Esq. via email at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7GhEhqhdfg0ze3NJhUJjd__xNDtBQWXkdaBk2y6LOsXY4e9KYVWQInayIf7GSFRhhZunwbuIgmjY2RovxsgHWAHy3s0CEHDmswCqT4rYMXM=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.<\/p>\n<p>\n        <strong>CASE DETAILS: <\/strong>The filed complaint alleges that defendants made false statements and\/or concealed that: (1) defendants materially overstated the progress Telix had made with regard to prostate cancer therapeutic candidates; (2) defendants materially overstated the quality of Telix\u2019s supply chain and partners; and (3) as a result, defendants\u2019 statements about Telix\u2019s business, operations, and prospects, were materially false and misleading and\/or lacked a reasonable basis at all relevant times.<\/p>\n<p>\n        <strong>WHAT&#8217;S NEXT? <\/strong>If you suffered a loss in Telix Pharmaceuticals Ltd. during the relevant time frame, you have until <strong>January 9, 2026<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>\n        <strong>NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <strong>There is no cost or obligation to participate.<\/strong><\/p>\n<p>\n        <strong>WHY LEVI &amp; KORSINSKY: <\/strong>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/>Joseph E. Levi, Esq.<br \/>Ed Korsinsky, Esq.<br \/>33 Whitehall Street, 27th Floor<br \/>New York, NY 10004<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7GhEhqhdfg0ze3NJhUJjd__xNDtBQWXkdaBk2y6LOsX1U8E7-v50m_5VJ_LFPMBAwBq3CPKdp2uAJiS7VrmXQ5JL-06rFzq7HeoxL01zSVY=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a>\u00a0<br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g5dTEw8lQ8L93pkrJxTgv9l5T-c2o2EJiguCVlk_ghiOfHQigsFNBRv8M6hj4F5Jdg5dfNCFVvrK50EXNBZbYA==\" rel=\"nofollow\" target=\"_blank\">www.zlk.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTY0NyM3MjkxMDAwIzIwMjA0MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTcwNTA3ZTUtMmRlMy00MmQ4LWI3ZmUtNzNmZjc4ZDE4ODVjLTEwMzIyOTMtMjAyNS0xMS0yNS1lbg==\/tiny\/Levi-Korsinsky-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in\u00a0Telix Pharmaceuticals Ltd. (&#8220;Telix Pharmaceuticals Ltd.&#8221; or the &#8220;Company&#8221;) (NASDAQ: TLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Telix Pharmaceuticals Ltd. investors who were adversely affected by alleged securities fraud between February 21, 2025 and August 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/telix-pharmaceuticals-ltd-lawsuit-submission-form?prid=178928&amp;wire=3 TLX investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) defendants materially overstated the progress Telix had &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-913861","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in\u00a0Telix Pharmaceuticals Ltd. (&#8220;Telix Pharmaceuticals Ltd.&#8221; or the &#8220;Company&#8221;) (NASDAQ: TLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Telix Pharmaceuticals Ltd. investors who were adversely affected by alleged securities fraud between February 21, 2025 and August 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/telix-pharmaceuticals-ltd-lawsuit-submission-form?prid=178928&amp;wire=3 TLX investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) defendants materially overstated the progress Telix had &hellip; Continue reading &quot;TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-25T22:12:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTY0NyM3MjkxMDAwIzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline\",\"datePublished\":\"2025-11-25T22:12:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\"},\"wordCount\":382,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MTY0NyM3MjkxMDAwIzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\",\"name\":\"TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MTY0NyM3MjkxMDAwIzIwMjA0MjY=\",\"datePublished\":\"2025-11-25T22:12:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MTY0NyM3MjkxMDAwIzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MTY0NyM3MjkxMDAwIzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","og_locale":"en_US","og_type":"article","og_title":"TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","og_description":"NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in\u00a0Telix Pharmaceuticals Ltd. (&#8220;Telix Pharmaceuticals Ltd.&#8221; or the &#8220;Company&#8221;) (NASDAQ: TLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Telix Pharmaceuticals Ltd. investors who were adversely affected by alleged securities fraud between February 21, 2025 and August 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/telix-pharmaceuticals-ltd-lawsuit-submission-form?prid=178928&amp;wire=3 TLX investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) defendants materially overstated the progress Telix had &hellip; Continue reading \"TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-25T22:12:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTY0NyM3MjkxMDAwIzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline","datePublished":"2025-11-25T22:12:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/"},"wordCount":382,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTY0NyM3MjkxMDAwIzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","name":"TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTY0NyM3MjkxMDAwIzIwMjA0MjY=","datePublished":"2025-11-25T22:12:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTY0NyM3MjkxMDAwIzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTY0NyM3MjkxMDAwIzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tlx-lawsuit-alert-levi-korsinsky-notifies-telix-pharmaceuticals-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TLX LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913861","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=913861"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913861\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=913861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=913861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=913861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}